Decrim Update: Arizona Unanimously Approves Psilocybin Research Bill

The article Decrim Update: Arizona Unanimously Approves Psilocybin Research Bill was originally published on Microdose.

Arizona, a historically conservative state, has just approved a bill to research psilocybin mushrooms for therapeutic purposes.

The bipartisan measure unanimously passed the House Military Affairs & Public Safety Committee 15-0. The bill would support the research of psilocybin mushrooms, allocating $30 million in grants over three years. The goal would be to study the effects of psychedelics on a variety of conditions including depression, anxiety, PTSD, and substance abuse.

Research would focus on… 

“using whole mushroom psilocybin cultivated under a Schedule I license issued by the United States Drug Enforcement Administration (DEA)” and “using veterans, first responders, frontline health care workers and persons from underserved communities as the research subjects.”

Grants would also be given for use on phase I, II and III clinical trials aimed at “whole mushroom psilocybin” for FDA approval. 

This measure would not legalize psilocybin use, but is a definite step forward and shows for psychedelic research in varied jurisdictions across the US. 

Today HB 2486 (clinical research; psilocybin; grants; appropriation) passed MAPS Committee by a unanimous vote of 15-0! Thank you to brave bipartisan lawmakers sponsoring this bill to study veterans & first responders! @KevinPayne4AZ @TJShopeforAZ @JenLongdon @TraversforAZ pic.twitter.com/f3G7iJEF8E

— Sue Sisley, MD (@suesisleymd) February 13, 2023

For more decrim news, check out Virginia & Hawaii Move Psychedelic Decrim Bills Forward

psilocybin
psychedelic
depression
anxiety
ptsd
fda
research
legalize
clinical trials
clinical research